3-120674901-CT-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000187.4(HGD):c.175del(p.Ser59AlafsTer52) variant causes a frameshift, splice region change. The variant allele was found at a frequency of 0.0000781 in 1,600,586 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000084 ( 0 hom. )
Consequence
HGD
NM_000187.4 frameshift, splice_region
NM_000187.4 frameshift, splice_region
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.97
Genes affected
HGD (HGNC:4892): (homogentisate 1,2-dioxygenase) This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-120674901-CT-C is Pathogenic according to our data. Variant chr3-120674901-CT-C is described in ClinVar as [Pathogenic]. Clinvar id is 3171.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-120674901-CT-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HGD | NM_000187.4 | c.175del | p.Ser59AlafsTer52 | frameshift_variant, splice_region_variant | 3/14 | ENST00000283871.10 | NP_000178.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HGD | ENST00000283871.10 | c.175del | p.Ser59AlafsTer52 | frameshift_variant, splice_region_variant | 3/14 | 1 | NM_000187.4 | ENSP00000283871 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152112Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152112
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251276Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135810
GnomAD3 exomes
AF:
AC:
30
AN:
251276
Hom.:
AF XY:
AC XY:
26
AN XY:
135810
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000835 AC: 121AN: 1448356Hom.: 0 Cov.: 27 AF XY: 0.000111 AC XY: 80AN XY: 721478
GnomAD4 exome
AF:
AC:
121
AN:
1448356
Hom.:
Cov.:
27
AF XY:
AC XY:
80
AN XY:
721478
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74442
GnomAD4 genome
AF:
AC:
4
AN:
152230
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Alkaptonuria Pathogenic:7Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Mar 09, 2016 | - - |
not provided, no classification provided | literature only | GeneReviews | - | Frequent frameshift variant - |
Pathogenic, no assertion criteria provided | research | Department Of Human Genetics, Institute Of Clinical And Translational Research, Biomedical Research Center, Slovak Academy Of Sciences | - | The variant was originally described in AKU patient in PMID:10594001. It has been submitted to the HGD gene mutation database (http://hgddatabase.cvtisr.sk/, DB-ID: AKU_00013). - |
Pathogenic, criteria provided, single submitter | clinical testing | Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 22, 2023 | This sequence change creates a premature translational stop signal (p.Ser59Alafs*52) in the HGD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HGD are known to be pathogenic (PMID: 12501223, 19862842). This variant is present in population databases (rs587776556, gnomAD 0.08%). This premature translational stop signal has been observed in individual(s) with alkaptonuria (PMID: 10594001, 12872836, 18945288, 19862842, 25681086). It has also been observed to segregate with disease in related individuals. This variant is also known as p.R58fs. ClinVar contains an entry for this variant (Variation ID: 3171). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 26, 2022 | The p.Ser59AlafsX52 variant in HGD has been reported in at least 7 individuals with alkaptonuria and segregated with disease in 5 affected individuals from 4 families (Beltran-Valero 1999 PMID: 10594001, Uyguner 2003 PMID: 12872836, Abdulrazzaq 2009 PMID: 18945288, Usher 2015 PMID:25681086, Akbaba 2020 PMID: 31927521). It has also been identified in 0.06% (3/4828) of South Asian and 0.001% (1/68026) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 3171). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 59 and leads to a premature termination codon 52 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the HGD gene is an established disease mechanism in autosomal recessive alkaptonuria. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive alkaptonuria. ACMG/AMP Criteria applied: PVS1, PP1_Strong, PM3_Strong. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2003 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The frameshift variant c.175del p.Ser59AlafsTer52 in the HGD gene has been reported previously in homozygous and compound heterozygous states in multiple individuals affected with Alkaptonuria Kisa et al., 2021; Usher et al., 2015. This c.175delA has been reported as the most common variant among Alkaptonuria patients. This variant is reported with the allele frequency 0.01% in the gnomAD Exomes and novel not in any individuals in 1000 Genomes. It is submitted to ClinVar as Pathogenic Multiple submissions. This variant is predicted to cause a loss of normal protein function through protein truncation. Loss of function variants has been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | May 03, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | HGD: PVS1, PM2, PM3 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at